Evidence map›Paper›PMID 39273301›Full record

ArticleInternational journal of molecular sciences2024

Impact of a Functional Dairy Powder and Its Primary Component on the Growth of Pathogenic and Probiotic Gut Bacteria and Human Coronavirus 229E.

Vu Bao Dang, Muhammad A Alsherbiny, Ruohui Lin, Yumei Gao, Chunguang Li, Deep Jyoti Bhuyan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vu Bao DangNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.
Muhammad A AlsherbinyPharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0001-9337-2441
Ruohui LinAustralian Dairy Park Pty Ltd., 120 Frankston Gardens Drive, Carrum Downs, VIC 3201, Australia.
Yumei GaoAusnutria Pty Ltd., 25-27 Keysborough Avenue, Keysborough, VIC 3173, Australia.
Chunguang LiNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.ORCID 0000-0002-7789-2209
Deep Jyoti BhuyanNICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.ORCID 0000-0002-9736-0197

Funding

Australian Dairy Park P00027470Western Sydney University P00027470
6 · The paper itself

Abstract

Milk boasts an array of potent bioactive compounds, such as lactoferrin (Lf), immunoglobulins, and functional proteins, all delivering substantial therapeutic benefits. In this study, Immune Powder (a functional dairy formulation) and its primary component called Fractionated Milk Protein (FMP) containing Lf, zinc, and immunoglobulins and formulated by Ausnutria Pty Ltd. were evaluated for their potential broad-spectrum pharmacological activity. In particular, this study investigated the antibacterial (against pathogenic

Indexed as

PowdersProbioticsAnimalsAnti-Bacterial AgentsAntiviral AgentsCoronavirusDairy ProductsEscherichia coliGastrointestinal MicrobiomeHumansMacrophagesMiceMilk ProteinsNitric OxidePrebioticsRAW 264.7 CellsAnti-Bacterial AgentsAntiviral AgentsMilk ProteinsNitric OxidePowdersPrebioticsfunctional milk productgut bacteriahuman coronavirus 229Ein vitro digestionprobioticproteomics

Identifiers

PMID39273301
PMCPMC11394815

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.